NCT04908176 2024-12-13A Drug-drug Interaction Study of Avapritinib and MidazolamBlueprint Medicines CorporationPhase 1 Completed10 enrolled
NCT02857270 2022-11-22A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerEli Lilly and CompanyPhase 1 Completed210 enrolled